Benzinga's Top Downgrades
- JP Morgan downgraded HB Fuller Co (NYSE: FUL) from Overweight to Neutral. H.B. Fuller shares rose 0.46 percent to close at $48.50 on Tuesday.
- Analysts at Baird downgraded Boot Barn Holdings Inc (NYSE: BOOT) from Outperform to Neutral. Boot Barn shares fell 2.21 percent to $15.96 in pre-market trading.
- Berenberg downgraded Freeport-McMoRan Inc (NYSE: FCX) from Hold to Sell. Freeport-McMoRan shares rose 3.01 percent to $15.42 in pre-market trading.
- Jefferies downgraded W. R. Grace & Co (NYSE: GRA) from Buy to Hold. The price target for W. R. Grace has been lowered from $80 to $70. W. R. Grace shares gained 0.92 percent to close at $67.01 on Tuesday.
- Analysts at Bernstein downgraded F5 Networks, Inc. (NASDAQ: FFIV) from Outperform to Market Perform. F5 Networks shares rose 0.14 percent to close at $142.81 on Tuesday.
- Piper Jaffray downgraded Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) from Overweight to Neutral. Arrowhead Pharmaceuticals shares fell 59 percent to $1.80 in pre-market trading.
- Analysts at DA Davidson downgraded Texas Capital Bancshares Inc (NASDAQ: TCBI) from Buy to Neutral. Texas Capital Bancshares shares gained 0.42 percent to close at $71.60 on Tuesday.
- Chardan Capital downgraded Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) from Buy to Neutral. The price target for Arrowhead Pharmaceuticals has been lowered from $8 to $2. Arrowhead Pharmaceuticals shares fell 59 percent to $1.80 in pre-market trading.
- Maxim Group downgraded Mantech International Corp (NASDAQ: MANT) from Buy to Hold. Mantech shares rose 0.74 percent to close at $44.83 on Tuesday.
Latest Ratings for FUL
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2021 | Baird | Upgrades | Neutral | Outperform |
Dec 2020 | Citigroup | Upgrades | Neutral | Buy |
Sep 2020 | Deutsche Bank | Maintains | Hold |
View More Analyst Ratings for FUL
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top DowngradesDowngrades Analyst Ratings